查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1916656

全球生物活性胜肽和营养保健品成分市场预测至2032年：按来源、成分类型、剂型、作用机制、通路、应用和地区划分

Bioactive Peptides & Nutraceutical Ingredients Market Forecasts to 2032 - Global Analysis By Source, Ingredient Type, Form, Mechanism, Distribution Channel, Application, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，全球生物活性胜肽和营养保健成分市场预计将在 2025 年达到 591.2 亿美元，并在 2032 年达到 980.9 亿美元。

预计在预测期内，生物活性胜肽和营养保健成分食品将以7.5%的复合年增长率成长。这类食品不仅符合标准营养需求，还富含多种有益健康的化合物。生物活性胜肽来自蛋白质分解，在改善免疫反应、心臟健康、消化和新陈代谢方面发挥重要作用。益生菌、抗氧化剂、植物萃取物、维生素和矿物质等营养保健成分有助于促进健康和降低健康风险。这些食品融合了营养和治疗功效，透过日常饮食摄入，支持长期健康、功能表现和预防保健。

世界人口老化

随着消费族群老化，人们越来越倾向于选择能够支持健康老龄化、增强免疫功能、维持肌肉健康和提升认知功能的营养成分。生物活性胜肽因其在心血管健康、骨骼强健和代谢调节方面的益处而广受认可。随着预期寿命的延长，预防性营养比被动式医疗保健方案更受重视。富含胜肽的营养保健品正透过膳食补充剂和强化食品被纳入日常饮食中。医疗保健专业人员也建议使用基于胜肽的营养来管理与老龄化相关的慢性疾病。这种人口结构的变化正在已开发国家和新兴国家稳步扩大消费群。

生物有效性的复杂性

肽类物质极易受到消化酵素的影响，口服后可能降低其疗效。因此，需要先进的包封和递送技术来确保其在加工、储存和消化过程中的稳定性。个体吸收率的差异进一步增加了产品标准化的难度。製造商必须投入大量资金进行临床试验以证实其疗效。监管机构对功能性益处的审查也会增加研发时间和成本。这些技术和科学上的复杂性可能会阻碍胜肽类营养保健品的快速商业化。

植物来源与纯素趋势

出于伦理、环境和健康方面的考虑，消费者越来越倾向于寻找动物性胜肽的替代品。植物蛋白水解技术的进步使得从大豆、豌豆、大米和藻类等来源开发高效肽成分成为可能。纯素营养补充品在运动营养、体重管理和保健品领域正日益受到青睐。 「洁净标示」趋势也推动了天然生物活性化合物的应用。食品和补充剂品牌正在重新设计产品，以满足弹性素食者和纯素的需求。这种转变正在扩大其在全球营养补充品市场的适用范围。

来自合成替代品的竞争

合成替代品通常具有生产成本更低、配方稳定性更高的优势。这些成分因其可进行工程改造以实现特定功能，而备受大众市场製造商的青睐。此外，医药级合成化合物也受惠于完善的监管体系。另一方面，天然胜肽则需要大量的研究来证实其健康益处。价格敏感的市场可能更倾向于合成替代品而非生物基成分。这种竞争压力可能会影响天然生物活性胜肽的市场渗透率。

新冠疫情的影响：

新冠疫情显着影响了生物活性胜肽和营养保健品原料市场的需求模式。人们对免疫健康的日益关注带动了机能性食品和膳食补充剂消费量的增长。供应链中断初期影响了原料采购和生产营运。然而，数位化销售管道和电商平台有效弥补了传统零售通路的下滑。疫情期间，对增强免疫力胜肽的研究加速推进。监管机构也展现出柔软性，并加快了某些膳食补充剂的核准。即使在疫情结束后，消费者依然重视预防性营养，这将维持市场的长期成长。

预计在预测期内，生物活性胜肽细分市场将占据最大的市场份额。

由于肽类成分具有广泛的生理效应，预计在预测期内，生物活性胜肽细分市场将占据最大的市场份额。生物活性胜肽广泛应用于针对心臟健康、肌肉恢復、消化和免疫功能的膳食补充剂。其在临床和功能营养领域的确切疗效赢得了消费者的信赖。酶水解和萃取技术的不断进步正在提高胜肽的产量和性能。食品和饮料生产商正越来越多地将胜肽添加到功能性配方中。

预计在预测期内，化妆品和个人护理用品细分市场将呈现最高的复合年增长率。

预计在预测期内，化妆品和个人护理领域将保持最高的成长率。生物活性胜肽因其抗衰老、修復肌肤和促进胶原蛋白生成等功效而备受青睐。消费者对科学护肤方案的需求不断增长，加速了胜肽产品的普及。天然和生物来源的化妆品成分比合成化学物质更受青睐。胜肽类产品广泛应用于精华液、乳霜和针对特定肌肤问题的护肤配方中。高级产品和药用化妆品产品类型的成长进一步推动了市场需求。

占比最大的地区：

预计北美将在预测期内占据最大的市场份额，这得益于该地区消费者对功能性营养和健康保健的高度重视。众多膳食补充剂生产商和研究机构的存在，为产品创新提供了有力支撑。法律规范也促进了以科学为基础的膳食补充剂的系统化商业化。较高的可支配收入推动了消费者在高端膳食补充剂和机能性食品的支出成长。运动营养和健康老化领域在该地区尤为强劲。

年复合成长率最高的地区：

在预测期内，亚太地区预计将成为复合年增长率最高的地区，这主要得益于快速的都市化和饮食习惯的改变。不断壮大的中产阶级正在加大对健康和保健解决方案的投资。传统医学体係也将生物活性胜肽融入现代膳食补充剂中。中国、日本、印度和韩国等国家正崛起为重要的成长市场。产能扩张和原料的在地采购有助于提高成本效益。

免费客製化服务：

购买此报告的客户可以选择以下免费自订选项之一：

  • 公司概况
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 主要参与者（最多3家公司）的SWOT分析
  • 区域细分
    • 根据客户要求，提供主要国家的市场估算和预测以及复合年增长率（註：可行性需确认）。
  • 竞争标竿分析
    • 基于产品系列、地域覆盖范围和策略联盟对主要参与者进行基准分析

目录

第一章执行摘要

第二章 前言

  • 概括
  • 相关利益者
  • 调查范围
  • 调查方法
  • 研究材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球生物活性胜肽和营养保健成分市场（按来源划分）

  • 植物来源蛋白质和胜肽
  • 动物源性蛋白质和胜肽
  • 海洋来源的蛋白质和胜肽
  • 发酵衍生胜肽
  • 合成胜肽和成分

6. 全球生物活性胜肽和营养保健成分市场（按成分类型划分）

  • 生物活性胜肽
    • 胶原蛋白肽
    • 牛奶和酪蛋白胜肽
    • 蛋胜肽
    • 大豆和植物胜肽
  • 胺基酸和蛋白质组分
  • 益生元和益生菌
  • 植物化学和植物萃取物
  • Omega-3脂肪酸衍生物
  • 维生素、矿物质和特殊营养素

7. 全球生物活性胜肽和营养保健成分市场（按形式划分）

  • 粉末
  • 液体
  • 胶囊
  • 其他的

8. 全球生物活性胜肽和营养保健成分市场依作用机制划分

  • 抗氧化胜肽
  • 抗菌胜肽
  • 抗高血压胜肽
  • 免疫调节胜肽
  • 抗发炎胜肽
  • 体重管理与代谢胜肽

9. 全球生物活性胜肽和营养保健成分市场（按分销管道划分）

  • 直接B2B
  • 零售
    • 超级市场和大卖场
    • 专卖店
  • EC

第十章 全球生物活性胜肽和营养保健成分市场（按应用领域划分）

  • 营养补充品
  • 机能性食品和饮料
  • 药物与临床营养
  • 化妆品和个人护理
  • 动物营养与饲料
  • 其他的

第十一章 全球生物活性胜肽和营养保健成分市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 併购
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十三章：企业概况

  • Arla Foods Ingredients Group P/S
  • Peptan
  • Kerry Group plc
  • Roquette Freres
  • Glanbia plc
  • Danone SA
  • Royal DSM NV
  • Nestle SA
  • BASF SE
  • Hilmar Ingredients
  • Cargill, Incorporated
  • FrieslandCampina
  • Ingredion Incorporated
  • Ajinomoto Co., Inc.
  • Archer Daniels Midland Company（ADM）
Product Code: SMRC33229

According to Stratistics MRC, the Global Bioactive Peptides & Nutraceutical Ingredients Market is accounted for $59.12 billion in 2025 and is expected to reach $98.09 billion by 2032 growing at a CAGR of 7.5% during the forecast period. Bioactive Peptides & Nutraceutical Ingredients Foods refer to advanced food products enriched with health-promoting compounds that go beyond meeting standard dietary needs. Bioactive peptides, obtained from protein breakdown, play roles in improving immune response, heart health, digestion, and metabolism. Nutraceutical ingredients such as probiotics, antioxidants, botanical extracts, vitamins, and minerals contribute to enhanced wellness and reduced health risks. These foods integrate nutrition with therapeutic benefits, supporting long-term health, functional performance, and preventive healthcare through everyday dietary consumption.

Market Dynamics:

Driver:

Aging global population

Older consumers are increasingly seeking functional ingredients that support healthy aging, immunity, muscle maintenance, and cognitive function. Bioactive peptides are widely recognized for their benefits in cardiovascular health, bone strength, and metabolic regulation. As life expectancy increases, preventive nutrition is becoming a priority over reactive healthcare solutions. Nutraceutical formulations enriched with peptides are being incorporated into daily diets through supplements and fortified foods. Healthcare professionals are also recommending peptide-based nutrition to manage age-related chronic conditions. This demographic shift is steadily expanding the consumer base across both developed and emerging economies.

Restraint:

Complexity of bioavailability

Peptides are highly sensitive to digestive enzymes, which can reduce their efficacy when consumed orally. Ensuring stability during processing, storage, and digestion requires advanced encapsulation and delivery technologies. Variability in absorption rates among individuals further complicates product standardization. Manufacturers must invest heavily in clinical validation to demonstrate efficacy claims. Regulatory scrutiny around functional benefits also increases development timelines and costs. These technical and scientific complexities can restrain faster commercialization of peptide-based nutraceuticals.

Opportunity:

Plant-based & vegan shift

Consumers are increasingly demanding alternatives to animal-derived peptides due to ethical, environmental, and health concerns. Advances in plant protein hydrolysis are enabling the development of effective peptide ingredients from sources such as soy, peas, rice, and algae. Vegan nutraceuticals are gaining traction in sports nutrition, weight management, and wellness supplements. Clean-label trends are further supporting the adoption of naturally derived bioactive compounds. Food and supplement brands are reformulating products to cater to flexitarian and vegan consumers. This transition is expanding application potential across global nutraceutical markets.

Threat:

Competition from synthetic alternatives

Synthetic alternatives often offer lower production costs and higher formulation stability. These ingredients can be engineered for targeted functionality, making them attractive to mass-market manufacturers. Pharmaceutical-grade synthetic compounds also benefit from well-established regulatory pathways. In comparison, natural peptides require extensive research to validate health claims. Price-sensitive markets may prefer synthetic substitutes over bio-based ingredients. This competitive pressure can impact market penetration for naturally sourced bioactive peptides.

Covid-19 Impact:

The COVID-19 pandemic significantly influenced demand patterns in the bioactive peptides and nutraceutical ingredients market. Heightened awareness of immune health led to increased consumption of functional foods and dietary supplements. Supply chain disruptions initially affected raw material sourcing and manufacturing operations. However, digital sales channels and e-commerce platforms helped offset traditional retail slowdowns. Research activities related to immunity-enhancing peptides accelerated during the pandemic period. Regulatory agencies also showed flexibility in fast-tracking certain nutraceutical approvals. Post-pandemic, consumers continue to prioritize preventive nutrition, sustaining long-term market growth.

The bioactive peptides segment is expected to be the largest during the forecast period

The bioactive peptides segment is expected to account for the largest market share during the forecast period, driven by the wide range of physiological benefits associated with peptide-based ingredients. Bioactive peptides are extensively used in supplements targeting heart health, muscle recovery, digestion, and immunity. Their proven efficacy in clinical and functional nutrition applications supports strong consumer trust. Ongoing advancements in enzymatic hydrolysis and extraction technologies are improving peptide yield and performance. Food and beverage manufacturers are increasingly incorporating peptides into functional formulations.

The cosmetic & personal care segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cosmetic & personal care segment is predicted to witness the highest growth rate. Bioactive peptides are gaining popularity for their anti-aging, skin repair, and collagen-boosting properties. Increasing consumer demand for science-backed skincare solutions is accelerating peptide adoption. Natural and bio-derived cosmetic ingredients are preferred over synthetic chemicals. Peptides are widely used in serums, creams, and dermal formulations for targeted skin benefits. Growth in premium and cosmeceutical product categories is further driving demand.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the region benefits from high consumer awareness regarding functional nutrition and preventive healthcare. Strong presence of nutraceutical manufacturers and research institutions supports product innovation. Regulatory frameworks allow structured commercialization of evidence-backed nutraceuticals. High disposable incomes enable greater spending on premium supplements and functional foods. The sports nutrition and healthy aging segments are particularly strong in this region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rapid urbanization and changing dietary habits. Rising middle-class populations are increasingly investing in health and wellness solutions. Traditional medicine systems are also integrating bioactive peptides into modern nutraceutical formats. Countries such as China, Japan, India, and South Korea are emerging as key growth markets. Expanding manufacturing capabilities and local sourcing of raw materials support cost efficiency.

Key players in the market

Some of the key players in Bioactive Peptides & Nutraceutical Ingredients Market include Arla Foods Ingredients Group P/S, Peptan, Kerry Group plc, Roquette Freres, Glanbia plc, Danone S.A., Royal DSM N.V., Nestle S.A., BASF SE, Hilmar Ingredients, Cargill, Incorporated, FrieslandCampina, Ingredion Incorporated, Ajinomoto Co., Inc., and Archer Daniels Midland Company (ADM).

Key Developments:

In December 2025, BASF, San Fang Chemical Industrial Co., Ltd. and Nichetech Advanced Materials Co., Ltd. have signed a Memorandum of Understanding (MoU) to jointly develop sustainable solutions for the footwear industry, with a focus on thermoplastic polyurethane (TPU) products and a shared ambition to achieve net-zero carbon emissions by 2050.

In October 2025, Mars and Cargill, announced they are spurring the development of more than 224MWac* of new renewable energy capacity through five virtual power purchase agreements (PPAs) in Poland. The PPAs were signed with GoldenPeaks Capital, one of Europe's fastest-growing independent producers of renewable energy.

Sources Covered:

  • Plant-Derived Proteins & Peptides
  • Animal-Derived Proteins & Peptides
  • Marine-Derived Proteins & Peptides
  • Fermentation-Derived Peptides
  • Synthetic Peptides & Ingredients

Ingredient Types Covered:

  • Bioactive Peptides
  • Amino Acids & Protein Fractions
  • Prebiotics & Probiotics
  • Phytochemicals & Plant Extracts
  • Omega-3 & Fatty Acid Derivatives
  • Vitamins, Minerals & Specialty Nutrients

Forms Covered:

  • Powder
  • Liquid
  • Capsules
  • Other Foams

Mechanisms Covered:

  • Antioxidant Peptides
  • Antimicrobial Peptides
  • Antihypertensive
  • Immune-Regulating Peptides
  • Anti-Inflammatory
  • Weight Management & Metabolic Peptides

Distribution Channels Covered:

  • Direct B2B
  • Retail
  • E-Commerce

Applications Covered:

  • Nutraceuticals & Dietary Supplements
  • Functional Food & Beverages
  • Pharmaceuticals & Clinical Nutrition
  • Cosmetic & Personal Care
  • Animal Nutrition & Feed
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Source

  • 5.1 Introduction
  • 5.2 Plant Derived Proteins & Peptides
  • 5.3 Animal Derived Proteins & Peptides
  • 5.4 Marine Derived Proteins & Peptides
  • 5.5 Fermentation Derived Peptides
  • 5.6 Synthetic Peptides & Ingredients

6 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Ingredient Type

  • 6.1 Introduction
  • 6.2 Bioactive Peptides
    • 6.2.1 Collagen Peptides
    • 6.2.2 Milk & Casein Peptides
    • 6.2.3 Egg Peptides
    • 6.2.4 Soy & Plant Peptides
  • 6.3 Amino Acids & Protein Fractions
  • 6.4 Prebiotics & Probiotics
  • 6.5 Phytochemicals & Plant Extracts
  • 6.6 Omega 3 & Fatty Acid Derivatives
  • 6.7 Vitamins, Minerals & Specialty Nutrients

7 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Form

  • 7.1 Introduction
  • 7.2 Powder
  • 7.3 Liquid
  • 7.4 Capsules
  • 7.5 Other Foams

8 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Mechanism

  • 8.1 Introduction
  • 8.2 Antioxidant Peptides
  • 8.3 Antimicrobial Peptides
  • 8.4 Antihypertensive
  • 8.5 Immune Regulating Peptides
  • 8.6 Anti Inflammatory
  • 8.7 Weight Management & Metabolic Peptides

9 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Direct B2B
  • 9.3 Retail
    • 9.3.1 Supermarkets & Hypermarkets
    • 9.3.2 Specialty Stores
  • 9.4 E Commerce

10 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Application

  • 10.1 Introduction
  • 10.2 Nutraceuticals & Dietary Supplements
  • 10.3 Functional Food & Beverages
  • 10.4 Pharmaceuticals & Clinical Nutrition
  • 10.5 Cosmetic & Personal Care
  • 10.6 Animal Nutrition & Feed
  • 10.7 Other Applications

11 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Arla Foods Ingredients Group P/S
  • 13.2 Peptan
  • 13.3 Kerry Group plc
  • 13.4 Roquette Freres
  • 13.5 Glanbia plc
  • 13.6 Danone S.A.
  • 13.7 Royal DSM N.V.
  • 13.8 Nestle S.A.
  • 13.9 BASF SE
  • 13.10 Hilmar Ingredients
  • 13.11 Cargill, Incorporated
  • 13.12 FrieslandCampina
  • 13.13 Ingredion Incorporated
  • 13.14 Ajinomoto Co., Inc.
  • 13.15 Archer Daniels Midland Company (ADM)

List of Tables

  • Table 1 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Source (2024-2032) ($MN)
  • Table 3 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Plant Derived Proteins & Peptides (2024-2032) ($MN)
  • Table 4 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Animal Derived Proteins & Peptides (2024-2032) ($MN)
  • Table 5 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Marine Derived Proteins & Peptides (2024-2032) ($MN)
  • Table 6 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Fermentation Derived Peptides (2024-2032) ($MN)
  • Table 7 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Synthetic Peptides & Ingredients (2024-2032) ($MN)
  • Table 8 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Ingredient Type (2024-2032) ($MN)
  • Table 9 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Bioactive Peptides (2024-2032) ($MN)
  • Table 10 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Collagen Peptides (2024-2032) ($MN)
  • Table 11 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Milk & Casein Peptides (2024-2032) ($MN)
  • Table 12 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Egg Peptides (2024-2032) ($MN)
  • Table 13 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Soy & Plant Peptides (2024-2032) ($MN)
  • Table 14 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Amino Acids & Protein Fractions (2024-2032) ($MN)
  • Table 15 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Prebiotics & Probiotics (2024-2032) ($MN)
  • Table 16 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Phytochemicals & Plant Extracts (2024-2032) ($MN)
  • Table 17 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Omega 3 & Fatty Acid Derivatives (2024-2032) ($MN)
  • Table 18 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Vitamins, Minerals & Specialty Nutrients (2024-2032) ($MN)
  • Table 19 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Form (2024-2032) ($MN)
  • Table 20 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Powder (2024-2032) ($MN)
  • Table 21 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Liquid (2024-2032) ($MN)
  • Table 22 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Capsules (2024-2032) ($MN)
  • Table 23 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Other Foams (2024-2032) ($MN)
  • Table 24 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Mechanism (2024-2032) ($MN)
  • Table 25 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Antioxidant Peptides (2024-2032) ($MN)
  • Table 26 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Antimicrobial Peptides (2024-2032) ($MN)
  • Table 27 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Antihypertensive (2024-2032) ($MN)
  • Table 28 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Immune Regulating Peptides (2024-2032) ($MN)
  • Table 29 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Anti Inflammatory (2024-2032) ($MN)
  • Table 30 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Weight Management & Metabolic Peptides (2024-2032) ($MN)
  • Table 31 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 32 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Direct B2B (2024-2032) ($MN)
  • Table 33 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Retail (2024-2032) ($MN)
  • Table 34 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Supermarkets & Hypermarkets (2024-2032) ($MN)
  • Table 35 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 36 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By E Commerce (2024-2032) ($MN)
  • Table 37 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Application (2024-2032) ($MN)
  • Table 38 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Nutraceuticals & Dietary Supplements (2024-2032) ($MN)
  • Table 39 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Functional Food & Beverages (2024-2032) ($MN)
  • Table 40 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Pharmaceuticals & Clinical Nutrition (2024-2032) ($MN)
  • Table 41 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Cosmetic & Personal Care (2024-2032) ($MN)
  • Table 42 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Animal Nutrition & Feed (2024-2032) ($MN)
  • Table 43 Global Bioactive Peptides & Nutraceutical Ingredients Market Outlook, By Other Applications (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.